Christoph Westphal Resigns as Sirtris Pharmaceuticals CEO, Takes Over GlaxoSmithKline's SR One Venture Arm
Xconomy -- Christoph Westphal is leaving his CEO job at Sirtris Pharmaceuticals, the Cambridge, MA-based developer of drugs that target genes linked to the aging process, to get back into the venture capital game, according to an e-mail Westphal sent to friends and colleagues as well as Xconomy.